Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Post Pterygium Excision
NCT01736449Phase 4Completed
- Sponsor
- Arrowhead Regional Medical Center
- Start
- Apr 2011
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bevacizumab in pterygium (2 arms), sponsored by Arrowhead Regional Medical Center. Primary endpoint: Number of recurrent pterygia at 6 months. Started Apr 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT01736449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736449.